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I WashingtonUniversity in StLouis
SCHOOL OF MEDICINE
R. Gilbert Jost, MD
Interim Chair, Department of Radiology
Interim Director of the Institute

Dear Colleagues and Friends of Mallinckrodt Institute:
Chancellor Mark Wrighton recently presented to the academic community a new logotype for Washington University in St. Louis—a logo that
"draws upon our history, traditions, and location." The logotype was
heartily approved by the University Council and the Board of Trustees.
All departments and schools were encouraged to use the logotype as a
clear and consistent means of showing association with the University.
As we prepare to meet the challenges facing academic medicine, it is
extremely important that our national and international audiences
easily and consistently recognize the name of Mallinckrodt Institute
of Radiology as well as its affiliation with one of the nation's
top-ranked universities and medical schools. Therefore, I am pleased
to present the Institute's official, new logo, which has been approved
by the University and by the School of Medicine. A larger version of
the logo appears on the inside back cover of this publication.
Sincerely,

B om&0$R. Gilbert Jost, MD
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PROFILE: JOHN EICHLING, PHD

As Washington University's first radiation safety
officer, John Eichling was a vigilant sentinel for
one of the most extensive and diverse radiation
safety programs worldwide. At his retirement,
after 37 years at the medical center, he shares
memories of MIR's early days.

DIAGNOSING PULMONARY EMBOLISM

As part of a multi-institutional study, researchers
at Washington University Medical Center are evaluating spiral computed tomography as a diagnostic
tool for acute pulmonary embolism, a condition that
annually affects an estimated 600,000 patients in the
United States.

NEW HORIZONS IN SCREENING AND TREATING LUNG CANCER

SPOT NEWS

A collaborative effort among diagnostic radiologists,
nuclear physicians, and radiation oncologists to
assess diagnostic technology and cancer treatments
may lead to reduced mortality rates for lung cancer,
the leading cause of cancer deaths worldwide.

A TREATMENT ALTERNATIVE FOR PATIENTS
WITH AORTIC DISSECTION

20

FYI

Interventional radiologists, vascular and cardiothoracic surgeons, and cardiologists combine
radiological and endovascular techniques to provide revolutionary, minimally invasive treatments
for patients with thoracic aortic dissection.

ON THE COVER According to the American Cancer Society, an estimated 164,000 new
cases of lung cancer were diagnosed in the year 2000. If lung cancer is found and treated
early before it has spread to lymph nodes and other organs, the five-year survival rate
is about 42 percent. Doctors Farrokh Dehdashti, Richard Slone, and Jeffrey Bradley
(right) are working to boost patient survival. Photograph by Tim Parker.
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ASTRO Gold
Medal for
Purdy
James Purdy, PhD,
professor of radiology and
chief of the radiation oncology physics section,
received the American
Society for Therapeutic
Radiology and Oncology's
(ASTRO) highest honor, the
Gold Medal Award, at the
society's annual meeting in
Boston in late October.
Established in 1958,
ASTRO is the largest society
of radiation oncologists
worldwide. The first Gold
Medal Award was presented
in 1977 to highlight ASTRO
members' outstanding
contributions to radiation
oncology.

Purdy's research efforts
in computer-aided treatment
planning, particularly 3-D
conformal radiation therapy
(3-D CRT) and intensitymodulated radiation therapy
(IMRT), continue to have a
profound effect on the practice of radiation therapy. An
early advocate of 3-D CRT
quality assurance (QA),
Purdy now serves as director of the national 3-D QA
Center that oversees 3-D
CRT clinical trials. The
3-D QA Center is based at
Mallinckrodt Institute of
Radiology (MIR) and is
funded by the National
Cancer Institute.
Prior to joining the
MIR faculty in 1973, Purdy
trained with doctors Robert
Shalek and Gilbert Fletcher,
both former ASTRO Gold
Medal recipients, at the University of Texas M.D. Anderson Cancer Center. In his
acceptance speech, Purdy
said that at M. D. Anderson,
he "learned the importance
of the close interaction of
physicists and physicians
needed in a radiation oncology clinic." That interaction,
he added, continued with
his physician colleagues in
St. Louis, particularly
doctors Carlos Perez and
William Powers. Perez,
professor of radiology and
director of the Institute's
Radiation Oncology Center
for the past 25 years, and
Powers, who preceded
Perez as director, received
the ASTRO Gold Medal in
1992 and 1988, respectively.

Purdy was named chief
of radiation physics at MIR
in 1976 and was appointed
professor of radiology in
1983. He directs the physics
residency program, the first
such program to be approved
by the Commission of
Accreditation of Medical
Physics Education Programs. Purdy has authored
and coauthored more than
230 scientific articles and
book chapters and has
edited seven textbooks. He
also serves as senior physics
editor for The International
Journal of Radiation Oncology, Biology, and Physics.
Purdy is a former president and chairman of the
board of the American Association of Physicists in Medicine (AAPM) and a past
chairman of the Board of
Chancellors of the American
College of Medical Physics
(ACMP). In 1996 he received
the ACMP's Marvin M.D.
William Professional
Achievement Award and, in
1997, the AAPM's William D.
Coolidge Award—the two
highest honors bestowed
by United States medical
physics societies. He is a fellow of the American College
of Radiology, the ACMP, and
the AAPM.

Wippold
named neuroradiology chief
Franz Wippold, MD,
associate professor of radiology, was named chief of
MIR's neuroradiology section. He succeeds Daniel
Kido, MD, who left the Institute in late August to join the
faculty of Loma Linda University Medical Center
in California.
Wippold came to
Mallinckrodt Institute as a
fellow in neuroradiology,
having previous residency
training in neurology and in
radiology (chief resident,
diagnostic radiology) at
Walter Reed Army Medical
Center. Prior to joining the
MIR faculty in 1986, Wippold
was chief of neuroradiology
at Walter Reed and assistant
professor of radiology at the
Uniformed Services University of the Health Sciences
(USUHS) in Bethesda,
Maryland. Wippold currently
holds the academic title of
adjunct professor of radiology/nuclear medicine at the
F. Edward Hebert School of
Medicine, USUHS.
Wippold is a fellow of
the American College of
Radiology and of the American College of Angiology.
He received the MIR Fellow
Teaching Award in 1983 and
the Teacher of the Year
Award in 1991. He serves as
a reviewer for the medical
journals Radiology and the
American Journal of
Roentgenology.
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Researchers
share prize

RSNA awards
seed grants

Three pioneers in the
field of cognitive neuroscience received the 2001
Grawemeyer Award for
Psychology presented by
the University of Louisville,
Kentucky: Marcus Raichle,
MD; Steven Petersen, PhD;
and Michael Posner, PhD.
Raichle, professor of
radiology and of neurology
and neurobiology, and
codirector of MIR's Division
of Radiological Sciences;
Petersen, professor of neurology and neurobiology and
of radiology, and chief of
WUSM's neuropsychology
division; and Posner, a
Washington University alumnus and founding director of
the Sackler Institute at Weill
Medical College of Cornell
University, collaborated in
the mid-1980s to advance
the methods for isolating
and measuring the brain's
mental functions. Their
success in imaging the
brain's functions led to
discoveries of neuroanatomical networks that support
language and attention
processes.
The Grawemeyer
Foundation at the University
of Louisville annually
has awarded $1 million for
accomplishments in music
composition, education,
ideas improving world
order, and religion. This
year marks the first presentation of the Grawemeyer
Award for Psychology.

Programs sponsored by
the Radiological Society of
North America (RSNA)
Research and Education
Foundation annually assist
young investigators in the
early stages of their careers
in radiology research, education, and related scientific
disciplines. RSNA has
announced the presentation
of seed grants to the following Mallinckrodt Institute
physicians and scientists:
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■ Steven Don, MD, assistant
professor of radiology,
received an award of
$25,000 for his research
on "Exposure reduction
in neonatal chest radiography using computed
radiography."
■ James Duncan, MD, PhD,
assistant professor of
radiology, received a
$25,000 seed grant for his
investigation of "Optical
imaging of peripheral
vascular disease."
■ Jie Zheng, PhD, instructor
in radiology, received an
award of $25,000 for his
research on "Diagnosis of
pulmonary emboli with
MR perfusion and angiography: validation in a
porcine model."

Myerson and
Williamson
named ACR
fellows
At the American College of Radiology's (ACR)
annual meeting in September, Robert Myerson, PhD,
MD, a radiation oncologist,
and Jeffrey Williamson,
PhD, a radiation physicist,
were among the 96 outstanding clinicians and scientists
named as ACR fellows.
Fellowships are
awarded to ACR members
for significant accomplishments as a teacher of radiology, for scientific or clinical
research, or for service to
organized medicine. More
than 32,000 radiologists,
radiation oncologists, and
medical physicists support
the ACR's programs focusing on the practice of radiology and the delivery of
comprehensive radiological
health services.
Myerson joined the
MIR faculty in 1984 and was
appointed professor of radiology in 1997. He serves as
chairman of MIR's Radiation
Oncology Center Research
Committee and as chief of
the hyperthermia and GI
service. He was elected in
1999 as the North American
Hyperthermia Society's
councilor for medicine and
has been included in several
editions of The Best Doctors
in America. Myerson is a
member of the ACR's Com-

mittee on Residency Training in Radiation Oncology of
the Commission on Education. He was the associate
director of residency training
for MIR's Radiation Oncology Center from 1990 to
1998. He currently serves as
a manuscript referee for the
scientific publications Cancer; International Journal
of Radiation Oncology,
Biology, and Physics; International Journal of Hyperthermia; and Journal of
Clinical Oncology.
Williamson is professor
of radiology and associate
chief of the Radiation Oncology Center's physics
section. Prior to joining the
MIR faculty in 1989, he held
academic appointments at
the University of Arizona and
the University of Minnesota.
Williamson is a fellow of the
American Association of
Physicists in Medicine
(AAPM). He is associate
editor of the journal Medical
Physics and past associate
editor of The International
Journal of Radiation Oncology, Biology, and Physics.
He is a past member of
the AAPM's Board of Directors and currently serves
as chair of the AAPM Radiation Therapy Committee.
Williamson is a member of
the U.S. Nuclear Regulatory
Commission's Advisory Committee on Medical Use of Isotopes and serves on the Joint
ACR/American Society for
Therapeutic Radiology and
Oncology (ASTRO) Government Relations Committee.

As with many of life's
experiences that often
lead to memorable events,
the beginnings are usually
happenstance. Such was
John Eichling's career at Mallinckrodt Institute of Radiology (MIR).
In 1963 Eichling and his wife
Carol lived in Oklahoma, where he
was head of the Department of
Physics at Northeastern Oklahoma
State University. A native Oklahoman, Eichling earned a Bachelor
of Science degree at Northeastern
Oklahoma State and a master's
degree at Oklahoma University,
Norman.
Carol, a pre-med student,
had received a scholarship to
attend Washington University

The PET team (circa 1974).
Michel Ter-Pogossian
is at left front; John Eichling
is sixth from right.

John Eichling, PhD
professor of radiology and
Washington University's
radiation safety officer
by Kirstin Blase and Vicki Kunkler

School of Medicine (WUSM).
Although Eichling was not quite
sure what he would do in Missouri,
he knew this was a good opportunity for Carol. After Eichling
arrived in St. Louis, WUSM's
Dean Dempsey suggested Eichling
contact Michel Ter-Pogossian, a
research scientist who was planning the installation of a cyclotron
in the basement of Barnard Free
Skin and Cancer Hospital at Washington University Medical Center.
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As it turned out, this would be
tthe nation's first cyclotron installed
in a medical center and dedicated
to biomedical research. Armed
with a master's degree in nuclear
physics, Eichling was the first professional hired to work with the
WUSM cyclotron.
After 37 years at the medical
center, Eichling decided to retire
on December 31, 2000. He and
Carol plan to spend much of their
time on a 130-acre farm in Warren
County, Missouri. Portions of the
old farmhouse on the property were
built in 1820, and the Eichlings' passion for antiques and restoration
have turned the homestead into
"something of a museum and

by Mallinckrodt Institute was in
step with Doctor Sherwood Moore's
(MIR's first director) visionary plan
to keep the Institute at the forefront
of radiology technology developments. The early studies of
radionuclide brain tumor detection
conducted by Ter-Pogossian and
Dr. Henry Schwartz were milestones in nuclear medicine science.
The decision to install a cyclotron
at the new medical center and to
consolidate radioactive tracer production into a centralized radioisotope laboratory at Mallinckrodt
Institute came at a time when the
field of nuclear medicine was relatively new.
In 1963 MIR's nuclear
medicine group [The

This era, of course, was before
the advent of portable units, image
intensifiers, magnetic resonance
imaging (MRI), computed tomography (CT), positron emission tomography (PET), ultrasound imaging,
and dedicated mammography. In
fact, the Nuclear Regulatory Commission (NRC), the U.S. Department
of Energy, and the National Institutes of Health did not exist. The
University's first cyclotron was
funded by the Atomic Energy Commission, from which the NRC and
the Energy Research and Development Agency were formed.

...of Memories
private park." But before he turned
in his badges and closed his office
door for the last time, Eichling
shared some history and a bit of nostalgia about his early days at MIR.
The application of radionuclide
tracers to the biomedical sciences
began at Washington University
in the early 1930s, with the construction of a cyclotron on the University's main campus following
shortly thereafter. The construction
of the cyclotron and partial funding
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group officially became the Division of Nuclear Medicine in
1966.] was located on the fifth
floor of Barnard Hospital and was
comprised of only three pieces of
diagnostic equipment: a rectilinear
scanner, a thyroid uptake unit, and
a well counter for in vitro tests.
And the only types of equipment in
MIR's diagnostic radiology area
were fixed radiographic units for
taking individual films and several
fluoroscopic units.

Left: At his last Radiation Safety Committee meeting
in December, Eichling is shown with (left to right)
doctors Barry Seigel, Gilbert Jost, and Carlos Perez.
Above: A special memorabilia case was constructed
and presented to Eichling at the December Radiation
Safety Committee.

Most of the early radionuclide
research dealt with improving
images or intensifying images so
the radiation dose to the patient
could be reduced. Eichling was one
of a four- or five-member team
responsible for research and
cyclotron operation. It was a result
of Ter-Pogossian's encouragement
that Eichling pursued his doctorate
in biophysics. While working fulltime at MIR, Eichling attended
classes at Washington University
on a part-time basis. By 1970 he had
completed his doctoral research
on 0-15 compounds and their use
to successfully measure blood flow,
oxygen metabolism, and blood
volume in the brain.
Throughout his career, Eichling
says he has worked with some talented researchers on a diverse range
of projects, including Ter-Pogossian,
who led the research team that
developed PET; Mokhtar Gado, MD,
a neuroradiologist, as they demonstrated computed tomography's
ability to work on a quantitative
level; Marcus Raichle, MD, an internationally known neurologist/neurobiologist as they discovered that
water, when used as a radiotracer,
does not behave as a freely diffusible
marker in biological tissues; and the
team of radiologists Judy Destouet,
Barbara Monsees, and Louis Gilula,
and surgeon Leroy Young who developed and patented a radiolucent
breast implant medium.
In 1970 Eichling was asked by
Juan Taveras, MD, then director of
Mallinckrodt Institute, to serve as
radiation safety officer, a position
that would serve not only the Institute but the medical campus and
the main campus as well. Eventually more than 900 laboratories
working with radioactive materials
and medical programs, such as
nuclear medicine and radiation
oncology, would come under
Eichling's radiation safety watch.
According to Eichling, Washington

University has one of the most
extensive and diverse radiation
safety programs worldwide.
In 1970 the radiation safety
program consisted only of wearing
external monitors and testing field
sources. Since then, with the guidance of the NRC, a thorough program has been developed that now
includes extensive training in the
receiving, shipping, and handling
of radioactive materials; restricted
ordering; and laboratory inspections. The Radiation Safety group
performs many periodic internal
audits and on-site inspections to
evaluate the effectiveness of the
radiation safety program.
Eichling adds that he could not
have handled the tremendous radiation safety responsibilities without a
remarkable staff, including Jeanette
Hardin, Fritzi Imming, Larry Johnson, and Bonnie Kelly.
There is a multitude of information and regulation guidelines
covering every category of radiation safety, says Eichling. Currently
in the radiation safety group's
responsibilities are five gamma
irradiators; approximately 900
research laboratories; a large
nuclear medicine service; five
clinical chemistry groups; BarnesJewish Hospital north and south
campuses, Children's Hospital, and
Barnes-Jewish Hospital Heart Care
Institute; radiation oncology's
numerous accelerators for therapy;
and 160 diagnostic X-ray units.
During his Washington University career, Eichling says he has
been involved in "just about everything that is radiation-related at
Mallinckrodt Institute—research,
clinical, and education." He has
been a member of the Institutional
Radiation Safety Committee since
1970 and a member of the Radioactive Drug Research Committee
since its inception in 1975. He
was a charter member of the
Barnes Hospital Electrical Safety
Committee.
MALLINCKRODT INSTITUTE OFRADIOLOG)

Eichling hopes that former
coworkers will remember him
as someone who never rejected
a request for help and always
investigated a problem thoroughly.
An interesting footnote to
Eichling's career: Until his
retirement Eichling had never been
away for longer than a few days
because he wanted to be close by
in case the University needed him.
The most memorable aspect
of his career Eichling says was
"the opportunity to interact with
and deal with bright talented people. Working with the best in the
field has been a rare and enjoyable
experience." He says he specifically appreciated his long-time
work with doctors Carlos Perez
and Barry Seigel. And as his
colleagues would probably attest,
that feeling is mutual. EM

John Eichling is not only known for his dedication to the University and MIR, his
vast wealth of knowledge, and his kind caring manner. He also has a dry sense of humor.
In the early days of MIR, Eichling says that he and coworkers enjoyed "pulling
pranks" on each other. One of his favorite reminiscences follows:
When the cyclotron was first installed in 1964, the researchers wanted to measure the
energy of the deuteron beam. One way was to measure the distance the ionization path
traveled in air through a foil. When the lights were turned off in the cyclotron vault, the
ionization path would be visible—although the radiation level would be very high. Eichling
and Gene Hood, the cyclotron operator at the time, conspired to double-expose some films so
the visible ionization path would appear in the photographs as though it was apparently striking their hands or abdomens. When they presented the photos to William Powers, MD, then
director of MIR's Radiation Oncology Center, Powers was horrified. He told them in no
uncertain terms that they were fools and would probably expire in a few hours. Eichling says
he and Hood had to do a lot of explaining, but the incident did not inhibit future pranks.

The Washington University Medical Center
Cyclotron (circa 1964).
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DIAGNOSING

mania/ Embolism

A study at

According to the Ameri-

Mallinckiodt Institute

can Heart Association,

may benefit patients

pulmonary embolism

who develop

(PE) has become a
embolism.

national health problem in the
United States and other developed

by Vicki Kunkler

countries. An estimated 600,000
patients in the U.S. annually
develop PE, with women affected
more often than men. The disease
causes more than 60,000 deaths
each year.
Pamela Woodard, MD, assistant professor of radiology, is
Washington University Medical
Center's chief investigator for a
multi-institutional study to determine if contrast-enhanced spiral
computed tomography (CT) can
be used to definitively diagnose
acute PE. The study, called
Prospective Investigation in
Pulmonary Embolism Diagnosis-II
(PIOPED-II), is the second phase
of the original PIOPED study
that developed criteria for diagnosing PE by ventilation/perfusion
scintigraphy.

Pamela Woodard, MD
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Seven additional clinical
centers are participating in the
National Institutes of Healthfunded study: Cornell Medical
Center (New York City); Duke University (Durham, North Carolina);
Emory University (Atlanta); Henry
Ford Hospital (Detroit); University
of Calgary (Canada); University
of Michigan (Ann Arbor); and
Massachusetts General Hospital
(Boston). George Washington University (Maryland) will serve as the
study's data coordinating center.
PULMONARY EMBOLISM
PE is usually a result of deep
vein thrombosis (DVT). While DVT
and PE can occur in normal individuals, they are common complications in patients who have
undergone orthopedic surgery,
have cancer, or have other chronic
illnesses. Clots, called deep venous
thrombi, form in the deep veins
of the leg in areas where blood
flow is slower, or in veins that
have been exposed to direct
trauma. When emboli from the
deep venous thrombi break off,
they travel to the lungs, lodging in
the pulmonary arteries as pulmonary emboli. These emboli
obstruct pulmonary arterial blood
flow, causing shortness of breath,
sharp pleuritic chest pain, hypoxia,
and even death.
DVT and PE often occur
without warning. Because many
of the symptoms also occur with
other diseases, PE is difficult
to diagnose clinically, thus contributing to increased mortality,
prolonged hospitalization, and
increased healthcare costs.
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DETECTING AND TREATING PE
Ventiliation/perfusion scintigraphy, a nuclear medicine procedure that uses radioisotopes to
produce two-dimensional images
of lung ventilation and perfusion,
has been the most common
method used to diagnose acute
PE. Ventilation/perfusion scintigraphic studies are read as
"normal," "low-probability for
PE," "high-probability for PE,"
and "indeterminate," based on
previously determined criteria.
Although normal and high-probability results provide clinicians
with useful information, a large
number of patients have results
that are indeterminate. While
ventilation/perfusion scintigraphy
is highly sensitive in detecting pulmonary emboli, other etiologies
such as tumor or fibrosis can cause
similar ventilation/perfusion
results, producing false-positive
findings that result in unnecessary
treatment for patients.
In order to directly visualize
PE, pulmonary angiography can be
performed in patients who have an
indeterminate ventilation/perfusion lung scan. However, because
pulmonary angiography is an
invasive procedure, it is not often
performed.
An early diagnosis and an
aggressive treatment regimen can
save lives. Patients who are diagnosed with DVT or acute PE are
initially treated with intravenous
heparin, followed by three to six
months of an oral anticoagulant.
Patients with smaller emboli are
usually treated on an outpatient
basis, whereas those with larger
emboli are hospitalized.

SPIRAL CT
In the early 1970s, researchers
at Mallinckrodt Institute played a
key role in the development of the
medical application of CT, a technology that revolutionized the field
of radiology. For the first time in
medical history an imaging device
could produce cross-sectional
images of the body. The technology's direct visualization of internal anatomy allowed physicians to
differentiate between diseased and
healthy tissue, to detect blood
clots and enlarged organs, and to
detect early-stage tumors. Numerous studies conducted in the
following 20 years proved that the
specific and unique information
gained from the noninvasive CT
procedure could eliminate
exploratory surgery, shorten
hospital stays, and reduce actual
surgery time. In most cases CT has
replaced some of the more expensive radiological procedures, such
as angiography, lymphangiography,
and myelography.
In 1990 Mallinckrodt Institute
received one of the first spiral CT
units developed by Siemens Medical Systems, Inc. An improved
version of computed tomography,
spiral CT offers reduced scanning
time and lower risks to patients
with the use of nonionic contrast
material. Total scanning time
ranges from a few seconds up
to one-half minute. Volume CT
acquisition is achieved with the
patient taking a single breath-hold,
thus eliminating respiratory misregistration and image artifacts.

monary Embolism

Washington University PIOPED-II
Study Coinvestigators
Roger Yusen, MD, Department of Medicine,
Division of Pulmonary and Critical Care Medicine

Jay Heiken, MD, Mallinckrodt Institute of

In the PIOPED-II study
Woodard will use the latest
Siemens Medical Systems multidetector spiral CT system. This new
system with its four detectors can
scan four times faster and provide
four times better resolution than
the older single detector spiral
CT scanner.

Radiology, Division of Diagnostic Radiology
(computed body tomography)

Henry Royal, MD, Mallinckrodt Institute of
Radiology, Division of Nuclear Medicine

Daniel Brown, MD, Mallinckrodt Institute
of Radiology, Division of Diagnostic Radiology
(vascular and inter ventional radiology)

Brian Rubin, MD, Department of Surgery,
Division of General Surgery (vascular)

Audrea Lamb, RN, study coordinator

Sheila Agen, RT, research assistant

HIM 11

STUDY CRITERIA

Over the next 18 months the
national study hopes to enroll 133
patients at each study center,
based on the area's gender and
ethnic population. In St. Louis,
Woodard will begin recruiting
patients in September.
Volunteers for the study must
be 18 years of age or older and
suspected of having acute PE.
They may be
treated on either
an in- or outpatient basis.
Patients who
are allergic to
contrast media,
have renal insufficiency, or who
are pregnant
may not participate in the study.
Each patient will
undergo ventilation/perfusion
scintigraphy and
spiral CT. A nonionic contrast
agent will be used
during the spiral
CT scan. Some
patients may
also undergo
pulmonary

angiography and ultrasonography
of the lower extremities. Follow-up
assessments wiU be conducted at
one, three, and six months following enrollment. EM
Editor's note: Physicians who are
interested in enrolling patients in
the PIOPED-II study can contact
the patient coordinator, Audrea
Lamb, RN, at 314-855-5393
(pager) or 314-747-4633 (office).

Contrast-enhanced multidetector spiral CT images
demonstrate emboli (PE) in bilateral lower lobe
pulmonary arteries.
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Cancer
Radiation oncologists,
diagnostic radiologists,
and nuclear physicians
at Mallinckrodt Institute
of Radiology are working
toward the common
goal of reducing lung
cancer mortality rates.
by Candace O'Connor

ung cancer is a formidable disease. Every
year, it kills nearly

lung cancer than of breast, colon,
and prostate cancers combined,
Lung cancer is difficult to

160,000 men and women—most
of them smokers—and accounts for
some 28 percent of all cancer deaths

detect in time for a cure. Although
tiny breast cancers turn up on mammograms, colon cancers are found

in the United States. It is, in fact, the
leading cause of cancer death worldwide. More people die as a result of

during colonoscopy, and prostate
cancers are detected through PSA
screening, there is no reliable

screening test to detect lung cancer
at an early, resectable stage. By the
time patients develop symptoms,
the cancer has usually invaded
their mediastinal lymph nodes—
and, despite the best chemotherapy
and radiation therapy available,
the five-year survival rate is only
10 to 15 percent.
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"However, lung cancer is so
common that even a small impact
made on this disease can have a
huge effect in the number of
patients saved," says Jeffrey
Bradley, MD, a radiation oncologist
and chief of thoracic service at
Mallinckrodt Institute of Radiology's (MIR) Radiation Oncology
Center. "For example, if we can
bump that survival rate up to
twenty percent, we can save about
eight thousand more lives in one
year. So, new diagnostic tools and
techniques can make a great difference to patients."
From the latest screening
methods to newer, more aggressive
therapies, MIR's radiologists and
radiation oncologists are aggressively fighting nonsmall cell lung
cancer while working to boost
patient survival.
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Richard Stone, MD

Lung Cancer Screening
In August 2000, Richard Slone,
MD, associate professor of radiology, received a grant of nearly
$400,000 from the National Cancer
Institute (NCI) to participate in a
pilot project called the Lung
Screening Study. The study would
assess the effectiveness of spiral
computed tomography (CT), as
compared to conventional chest
X rays, in detecting asymptomatic
lung cancer. The study, involving
some 3,000 patients at six centers
nationwide, would recruit people
from 55 to 74 years of age who
were current heavy smokers or
were past smokers who had quit
within the previous 10 years.
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The NCI sponsored this pilot
project to test the feasibility of
conducting a much larger, more
definitive study that would again
examine the efficacy of spiral CT
for lung cancer screening and
would also follow the patients longterm. There were some stumbling
blocks for the project: Could Washington University and the other
centers recruit sufficient numbers
of patients in a short time? Could
they perform the exams, interpret
the studies, and handle the logistics
of sending reports to patients and
physicians?
Slone and his group answered
these questions with a resounding
"yes." In only 10 weeks, they managed to recruit, randomize, and
image 500 patients—half of the
patients received a single-view
chest X ray; half received a lowdose spiral chest computed tomography examination. Altogether, a
seven-member team worked fulltime to complete the study on this
fast-track schedule. Some of the
team came from Volunteer for
Health, an organization that
matches appropriate patients with
research studies, and helped in this
study by handling telephone calls,
patient eligibility checks, and
scheduling.

Lung Screening Study
Research Assistants
Roberta Yoffie, BS, RT, CCRC
Sheila Agan, RT, (R)(CT)
Danielle Gherardini, RN, BSN
Robin Haverman, RT (R)
Lora Crouch, BS, RT

The NCI was so pleased with
the Washington University team's
achievement that they awarded an
additional grant of nearly $40,000
to enroll an additional 100 patients
beyond the original contract of 500.
"We are considered one of the key
contributing centers to this study,
since we have been more successful than others at recruiting and
managing the caseload," says
Slone. "From the beginning, our
goal was to play a key role in the
next phase of this study."
Slone's research focused on
spiral CT, a technology that
requires the patient to lie on a movable table within the CT scanner
and hold one deep breath for 20
seconds while the CT detectors
rotate continually around the table.
The resulting scan offers a detailed
view of the chest, including the
lungs, and may reveal tiny abnormalities of just a few millimeters in
size. The researchers compared
these results to those of a chest
X ray, which was first tested as a
lung cancer screening tool during
the late 1970s and early 1980s.
Results showed that routine chest
X rays do not have a significant
impact on the ability to detect lung
cancer early.
Spiral CT is clearly a more sensitive, effective screening tool, and
Slone's team has proven that use
of spiral CT can be streamlined
enough to be implemented as
public health policy. However,
the economic feasibility of this
approach still needs to be resolved.
And another issue remains: Does
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spiral CT detect cancers early
enough to significantly impact the
outcome of treatment?
Over the coming year, Slone's
study group will follow patients
who have positive scans to see how
many of these abnormalities prove
to be cancerous. The researchers
also will track the number of
benign abnormalities that lead to
additional testing and even surgery,
with all the associated costs and
risks. The next, much larger phase
of testing, with its years of patient
follow-up, will provide still more
answers.
"We hope spiral CT will prove
to be a useful method for screening
asymptomatic lung cancers. If it
is useful, then what age groups of
patients should be targeted? How
much of a history of smoking
should patients have? How often
should patients be screened? We
want to shed light on some of these
questions," says Slone.

Lung Cancer Treatment
"allinckrodt Institute
radiation oncologists are
-involved in cutting-edge
intramural and cooperative group
protocols aimed at testing the latest lung cancer therapies and
improving patient care. In one pilot
intramural study, funded by a grant
from the Siteman Cancer Center at
Washington University Medical
Center, radiation therapists are
studying the use of CT combined
with positron emission tomography
(PET) to detect mediastinal lymph
node involvement.

M!

Figure 1B

Figure 1A and B:

SYNCHRONOUS PRIMARY LUNG CANCERS

Screening chest CT of asymptomatic 59 year-old man
who had smoked 2 to 3 packs of cigarettes per day
for over 30 years. Figure A shows lung destruction
from pulmonary emphysema as well as a 1.5-cm spiculated pulmonary nodule in right upper lobe (arrow),
highly suspicious for bronchogenic carcinoma. Figure
B shows a 2-cm tabulated nodule in left lower lobe
(arrow), also suspicious for bronchogenic carcinoma.
Figure 2:

NONBRONCHOGENIC MALIGNANCY

Screening chest

CT of asymptomatic 61 year-old man who had
smoked 1 to 2 packs of cigarettes per day for over
30 years. CT revealed a 3-cm tabulated mass in right
lower lobe (arrow), suspicious for lung cancer.
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Above: Jeffrey Bradley, MD

Developed at Mallinckrodt
Institute in the early 1970s, PET is
a noninvasive technique that uses
radio-pharmaceuticals to provide
vivid functional images of various
organ systems.
"CT scans alone have fifty to
sixty percent sensitivity and specificity in detecting this involvement,
but the addition of PET scanning
increases that number to eightyfive or ninety percent," says
Bradley. "So by fusing these two
types of imaging, the radiation therapist can target therapy more precisely to the primary tumor and
lymph nodes."
Washington University is one
of the leading patient recruiters
for lung cancer protocols sponsored by two large cooperative
groups: the Radiation Therapy
Oncology Group (RTOG) and the
Cancer and Leukemia Group B
(CALGB). One trial nearing completion is RTOG 9311, developed by
MIR's Radiation Oncology Center
physicians and physicists. The 150
patients in this trial have been
treated with doses
of 90-gray radiation or greater, an
increase over the usual dose of
60- or 70-gray, with no apparent
toxicity. These patients will be
followed until June 2001 to establish their long-term reactions.
Already, Bradley—in conjunction with medical oncologist
Ramaswamy Govindan, MD, and
former MIR staff member Mary
Graham, MD—has written a new
protocol, RTOG 1051, to follow the
9311 trial. This time,
the physicians will escalate the

dose of radiation therapy while
using concurrent chemotherapy
and will carefully gauge how high
the dose can safely be raised. The
data from this trial will be archived
in a queriable database headquartered at MIR and will contain a
wealth of knowledge about normal
tissue tolerance to radiation in the
chest.
Along with clinical trials, the
Institute is advancing lung cancer
therapy in other aspects of care. In
1991, the MIR Radiation Oncology
Center pioneered the clinical use of
three-dimensional conformal radiation therapy for planning and treatment. With the help of
sophisticated, imaged-based computers, researchers can create an
exact model of a patient's anatomy
that allows for more precise calculation of radiation doses. With this
technique, higher and more effective doses can be safely targeted to
the tumor, and potential toxicity
can be estimated and minimized.
Currently, MIR researchers
are also investigating an "active
breathing control device" that
teaches breath-holding techniques
to patients, thus stopping respiratory motion and improving the
delivery of radiotherapy.
The Radiation Oncology Center
will soon acquire a new, highly
sophisticated addition to the treatment arsenal: a state-of-the-art,
large-bore CT simulator used for
radiation therapy planning. While
standard simulators have a 70-centimeter bore, this scanner has an
85-centimeter opening that will
accommodate larger patients.

Below: These images represent an image-fused
volumetric CT scan and PET scan for the purposes of
radiation therapy planning. The gross tumor volume
is contoured in red on the CT images on the left.
The PET images show corresponding areas of FDG
accumulation on the right.
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Nuclear Medicine and
Lung Cancer
PET is one of the most important advances in imaging nonsmall cell lung cancer. The
technology is beneficial in both the
initial diagnosis and staging of lung
cancer, where it has proven to be
more sensitive and more specific
than other imaging modalities.
When patients are first diagnosed with a pulmonary nodule, CT
is most frequently used to characterize the nodule, but sometimes
follow-up CT scans or a biopsy is
needed to confirm. "PET is useful
for differentiating benign from
malignant nodules when the nodule
is indeterminate by CT," says Farrokh Dehdashti, MD, a nuclear
medicine physician and an associate professor of radiology.
Currently, PET is routinely
used at Washington University Medical Center, as well as other medical
facilities, to stage patients with nonsmall cell lung cancer. Mallinckrodt
Institute is currently participating
in a prospective multicenter trial,
sponsored by the American College
of Surgeons Oncology Group, to
further define the role of PET in
staging lung cancer.
In addition to detection and
staging lung cancer, PET has a
potential usefulness in monitoring
and assessing response to therapy
in patients with nonsmall cell lung
cancer.
Currently, Dehdashti and several colleagues—Mark Mintun, MD;
Jason Lewis, PhD; Michael Welch,
PhD; and Bradley and Govindan—
are involved in a promising
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research study, funded by a grant
from the National Institutes of
Health (NIH). This study will
assess a new positron-emitting
tracer [60Cu-labeled diacetyl-bis
(4N-methythiosemicarbazone)
(^Cu-ATSM)] that can measure
tumor hypoxia (oxygen deficiency), a critically important factor in tumor behavior. Tumors
with a high degree of hypoxia have
been shown to be more malignant,
more resistant to treatment, and
more likely to metastasize or recur.
Thus, these tumors require more
aggressive treatment.
In this study Dehdashti and
her colleagues studied nonsmall
cell lung cancers, using 60Cu-ATSM
to measure tumor hypoxia. Then
they compared the degree of
hypoxia measured by PET with
the patients' responses to therapy.
Although results were preliminary,
the team discovered an inverse
relationship between the degree of
tumor hypoxia and its response to
therapy: Patients with a low level
of hypoxia responded better to
treatment than did those with a
high degree of hypoxia. As these
results indicate, PET may have
an important impact on management of patients with nonsmall
cell lung cancer.
"This tracer will allow us to
study therapeutic approaches that
can improve tumor oxygenation by
directly assessing the effect of such
therapies on tumor hypoxia. This
new PET tracer will also help us
determine the regions of the tumor
that are more hypoxic and, therefore, more aggressive and resistant
to therapy," says Dehdashti. Dm

l\
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Furrokh Dehdashti, MD
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Aortic Dissection
The unique advantages of having
well-trained, experienced personnel and
state-of-the-art equipment at Mallinckrodt
Institute of Radiology is providing new
hope for patents with aortic dissection.

by Thomas Peters

Suresh Vedantham, MD

ortic dissection is
the most common
catastrophe of
the aorta. If left
untreated, 33 percent of patients
with aortic dissection die within
24 hours; by two weeks, the mortality rate approaches 75 percent.
Two thirds of the patients diagnosed
with aortic dissection are treated
immediately by surgical aortic
reconstruction, a procedure that is
very complex, requires a long recovery time, and can be life threatening
for these critically ill patients. Currently, at Mallinckrodt Institute of
Radiology (MIR) and at only a
few other medical centers in the
world, revolutionary nonsurgical
treatments are being created by
coupling cutting-edge radiological
and endovascular (inside the blood
vessel) techniques. Together these
nonsurgical approaches are quickly
becoming viable and durable alternatives to extensive reconstructive
surgical procedures for patients
with thoracic aortic dissection.
The aorta is a large, elastic,
multilayered blood vessel that
comes from the heart and supplies
blood to peripheral tissues and
organs. Aortic dissection refers to a
tear or hole in the inner elastic walls
of the aorta that results in pulsatile
blood flow moving through nonelastic outer layers of the aorta. In other
words, blood flow forges a new path
through the tear and into a very
weak outer wall of the aorta that
cannot respond well to the extreme
forces of blood pressure. Although
the exact causes of aortic dissection
are not clear, patients with hypertension (high blood pressure) or
Marian's disease are the most
common victims of this condition.
Over time this leak of pulsatile
blood flow into the weaker sur-

rounding layers of the aorta can
lead to complications, including
ballooning of the vessel walls
(aneurysms), interruption of
blood flow, and consequently oxygen to peripheral organs resulting
in organ damage and/or eventually
aortic rupture.
Suresh Vedantham, MD, a
vascular and interventional radiologist at Mallinckrodt Institute of
Radiology (MIR), is part of a multidepartmental effort at Washington
University Medical Center (WUMC)
to provide unique nonsurgical
options for patients with aortic dissection. "At our medical center, we
are fortunate to have a good team
approach for solving these types of
complex problems," says Vedantham. "The number of institutions
that have these cutting-edge treatment options is relatively small."

Figures 1A, IB, 1C:
BALLOON FENESTRATION
PROCEDURE TO RELIEVE
LEFT LEG ISCHEMIA IN A
PATIENT WITH AORTIC

Figure A: Digital
substruction
angiogram shows
severe collapse of
aortic channel, or
"true lumen,"
(arrowheads) that
brings blood to left
iliac artery and left

leg.
Figure B: Through 3
to 4 mm incisions in
each groin, a guided
needle (arrow) is
passed from left
iliac artery into
"false lumen" of
the aorta. A

Radiological diagnosis
Patients with aortic dissection
are often diagnosed with severe
chest pain, often with associated
ischemia (low oxygen), in one or
more organs. Once a patient is suspected of aortic dissection, imaging
procedures can be performed to further identify whether the patient
actually has aortic dissection.
Angiography, often considered
the standard radiological imaging
procedure for identifying aortic
dissections, has been replaced by
newer, less invasive methods.
Indeed, the aorta can be imaged
radiologically by transesophogeal
echocardiography (TEE), magnetic
resonance imaging (MRI), or helical
computed tomography (HCT).
According to Vedantham, Washington University Medical Center has
the most current TEE, MRI, and
HCT devices available.

catheter-mounted
heads) in the false
lumen is used as a
target for the
needle pass.
Figure C: After new
re-entry tear has
been dilated and
stented, angiogram
shows contrast
and, therefore,
blood flowing from
false lumen of the
aorta (arrows),
across newly
created fenestration, and into left
leg (arrowheads).

Figure 1C
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Figures 2A, 2B, 2C:
AORTIC STENT PLACEMENT IN A PATIENT WITH
AORTIC DISSECTION

Figure A: Digital
subtraction
angiogram shows
aortic dissection
(2 aortic channels,
labeled A and B)
with severe
collapse of true
lumen (arrows) of
aorta in chest and
upper abdomen.
Arteries supplying
liver, bowel, and
right kidney are not
seen because of
poor blood flow.
Artery to left kidney (arrowheads)
has very low blood
pressure.
Figure B:
Through a
3 to 4 mm
incision in the
groin, a metallic
stent is placed in
the aorta to expand
and support collapsed true lumen,

Figure 2B

permitting more

II

blood flow. Balloon

|

angioplasty will
expand stent to
proper size.
Figure C:
After stent
placement,
angiogram shows
re-expansion
of true lumen of
the aorta with

.

excellent blood

'

flow.
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"HCT is a great method for
scanning rapidly. We can scan the
aorta in sub-seconds, and this helps
to decide if the patient is a candidate for our aortic procedures," he
says. "HCT is quickly becoming the
best way to evaluate acute aortic
dissection and its complications."
After reviewing the radiological
images, determining if the tear
is in the descending aorta, and
consulting with the other team
members, patients are classified
into two groups.
Patients diagnosed with Stanford Type A dissection (involving
the ascending aorta) are immediately sent for surgical intervention
because of the high risk of aortic
rupture. Patients diagnosed with
Stanford Type B dissection (involving the descending aorta) without
complications are managed with
medications to reduce blood pressure and might be considered for
stent-grafts in the future.
Type B dissection patients who
do show complications of organ
ischemia were previously treated
with emergency aortic surgery,
but at Mallinckrodt Institute these
patients are now considered key
candidates for innovative, minimally invasive approaches. Dissection complications can now be
treated without the risks of major
aortic surgery at the Institute and at
a few other institutions worldwide.
However, Vedantham cautions
that "we never do these procedures
without input from vascular surgeons, cardiologists, and cardiothoracic surgeons. Everyone on our
medical team must collaboratively
decide what is best for the patient."

First generation of
nonsurgical treatments
According to Vedantham, the
nonsurgical treatment of aortic
dissection currently involves a "first
generation" of radiological intervention techniques, including balloon
fenestration and stent placement—
both effective methods for treating
the complications of dissection
but not the dissection itself. Each of
these techniques requires threading
the balloon or stent devices through
a catheter placed into an artery of
the leg, as well as close radiological
monitoring to help guide the
devices to the aorta. Vedantham
indicates these techniques are
preferred since "they are a small
operation through the groin instead
of a massive operation in the chest."
In balloon fenestration, the
interventional radiologist makes a
second, small tear in the aorta and
below the initial tear. The radiologist then uses an inflatable balloon
to prop this tear open, thereby
creating a small re-entry tear. This
re-entry tear brings the blood flow
back into the elastic-containing
inner walls of the aorta, restoring
blood flow into its important
branches. One disadvantage of the
balloon fenestration technique is
the risk of puncturing the aorta
with the needle used to create the
second tear—although this rarely
occurs with experienced interventional radiologists.
Stents are small, expandable,
metal mesh inserts that are placed
in collapsed blood vessels to allow
blood to again flow through the
blood vessel and to help prevent
future collapse of the blood vessel.
Although only a limited number
of patients have received the
stent placement procedure in the

MALLINCKRODT INSTITUTE OF RADIOLOGY

thoracic aorta, the procedure has
been effective in restoring blood
flow into the compromised aortic
branches, relieving the ischemia.
One disadvantage is that stent
placement often requires large
areas of blood vessels to be encompassed by these devices. Further
studies must be performed to
validate whether this is a viable
long-term solution for complicated
dissection.
Both of these techniques
require guidance by radiological
monitoring systems, including fluoroscopy (the standard procedure
for most hospitals) or the more
modern intravascular ultrasound,
which is available at MIR. "Having
access to intravascular ultrasound
is another way to minimize the
risks of the procedure. We can
give patients less contrast dyes and
prevent patients from developing
complications," he says.
Overall, these first-generation
techniques have been successful in
restoring blood flow to over 90 percent of ischemic organs in patients
with complicated dissection. However, remember the tear that gave
rise to the aortic dissection is often
not closed and, in the long term,
may become more pronounced or
may lead to further tears. Furthermore, each procedure is difficult to
translate to the general medical
community because these lengthy
procedures are performed on critically ill patients and require welltrained staff and state-of-the-art
radiological equipment available at
only a few centers in the country.
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Second generation of
treatments
A new "second generation"
approach that will soon be tested
at WUMC involves placing a stentgraft across the primary tear of the
dissection. The stent-graft is an
expandable tube with a wall,
whereas the stent is just expandable mesh used to prop open blood
vessels. Therefore, the stent-graft
can cover the region of the blood
vessel that has a tear and hold open
the blood vessel simultaneously.
"The number of patients
treated with stent-grafts is small,
but the graft is a promising solution. We are creating the repair
much like the surgeons do surgically, but we are not exposing the
patient to the upfront risks of
having major surgery on the
aorta," says Vedantham.
Current and future studies
Vedantham estimates that
minimally invasive alternatives to
aortic dissection are promising
because of these three factors:
improved biomaterials technology;
improvements in imaging, including HCT, intravascular ultrasound,
and digital subtraction angiography; and the current interest
of biotechnology companies in
pursuing less invasive methods
of treating vascular diseases. He
further explained that any procedure giving less invasive options
to critically ill patients with aortic
dissection requires further investigation of the long-term effects and
whether that procedure can be
expanded. Vedantham views
stent-grafts as a major advance
in the evolution of aortic dissection
treatments.

The Washington University
Medical Center team
Alan Braverman, MD, Internal Medicine
David Hovsepian, MD, Vascular and
Interventional Radiology
Daniel Picus, MD, Vascular and
Interventional Radiology
Luis Sanchez, MD, Vascular Surgery
Gregorio Sicard, MD, Vascular Surgery
Thoralf Sundt, MD, Cardiothoracic
Surgery
Suresh Vedantham, MD, Vascular and
Interventional Radiology

Local hospitals have referred
patients with Stanford Type B aortic dissection to WUMC with good
results, and Vedantham believes
the number of patient referrals will
probably increase. "We hope the
aortic stent-graft will develop into
a treatment that can be applied not
just to the complicated Type B
patients with ischemia but to all
Type B patients," he says.
Overall, Vedantham indicates
that the success of providing minimally invasive options to patients
with aortic dissection can only
occur through collaborative efforts,
involving interventional radiologists, vascular surgeons, cardiothoracic surgeons, cardiologists, and
attending critical care staff. EH3
Editor's note: Vedantham recently
coauthored "Nonoperative management of acute aortic dissection, " with Michael Dake, MD, of
Stanford University. The scientific material appears as a book
chapter in Current Therapy in Vascular Surgery.
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In this section, the names of employees who are full-time faculty or staff or who have an appointment in the Department
of Radiology are highlighted in boldface type.

PROMOTIONS
Richard LaForest, PhD,
research associate, was
promoted to instructor in
radiology, Division of
Radiological Sciences.
Mai Xu, PhD, research
associate, was promoted
to instructor in radiology,
Radiation Oncology Center.

NEW FACULTY
Deepa Chadha, MD,
instructor in radiology,
Division of Diagnostic
Radiology, Barnes-Jewish
St. Peters Hospital.
Mary Dyszlewski, PhD,
visiting instructor in radiology, Division of Radiological
Sciences.
Susan Langhorst, PhD,
CHP, assistant professor
of radiology, Division of
Radiological Sciences, and
radiation safety officer and
assistant director of environmental health and safety
for Washington University
Medical Center.
Jie Zheng, PhD, instructor
in radiology, Division of
Radiological Sciences.

JOINT
APPOINTMENTS
Thomas Conturo, MD, PhD,
associate professor of radiology and adjunct assistant
professor of physics, was
appointed adjunct associate
professor of physics and
adjunct associate professor
in biomedical engineering.

APPOINTMENTS/ELECTIONS
Kyongtae Bae, MD, PhD,
assistant professor of radiology, was elected to a threeyear term on the American
College of Radiology's
Committee on Drug and
Contrast.

Jason Sohn, PhD, assistant
professor of radiology, was
named president-elect of the
American Association of
Physicists in Medicine, Missouri River Valley Chapter.

Colin Derdeyn, MD, assistant professor of radiology,
was appointed to the Editorial Board of the American
Journal of Neuroradiology.

Sally Wagner-Schwarz,
MS, RPh, research instructor in radiology, was
appointed to the U.S.
Nuclear Regulatory Commission's Advisory Committee
on Medical Use of Isotopes.

Victor Song, PhD, research
associate, Department of
Chemistry, was appointed
instructor in radiology,
Division of Radiological
Sciences.

Eric Klein, MS, assistant
professor of radiology, was
appointed to two-year terms
on the American Society for
Therapeutic Radiology and
Oncology's Physics Committee and the Refresher
Course Subcommittee.

FIRST-YEAR
FELLOWS

Robert McKinstry, MD,
PhD, assistant professor of
radiology, was appointed
director of the neuroradiology fellowship training
program at Mallinckrodt
Institute.

Hiten Malde, MD, is a clinical fellow in neuroradiology.
He received an undergraduate degree from Valhind
College of Science, India,
and a medical degree from
Grant Medical College, India.
Malde completed four years
of training in diagnostic radiology at New York Medical
College, Valhalla.
Paul Wong, MD, is a clinical fellow in neuroradiology.
He received an undergraduate degree from Santa Clara
University, California, and
a medical degree from
St. Louis University, Missouri. Wong completed
four years of training in
diagnostic radiology at the
Kaiser Foundation Hospital,
Los Angeles.

Tom Miller, MD, PhD,
professor of radiology, was
appointed as a member of
the American Board of
Nuclear Medicine.
Scott Mirowitz, MD, professor of radiology, chief
of radiology at BarnesJewish Hospital north, and
codirector of body magnetic
resonance imaging, was
appointed by the Board of
Directors of the Radiological
Society of North America to
serve as chair of its Health
Policy and Practice Committee. Mirowitz has served on
the committee since 1998.

Jeffrey Williamson, PhD,
professor of radiology,
was appointed to the U.S.
Nuclear Regulatory Commission's Advisory Committee
on Medical Use of Isotopes.
Franz Wippold, MD, pro
fessor of radiology and chief
of neuroradiology, was
appointed to a one-year term
on the American College of
Radiology's Committee on
Education—Neuro, Commission on Neuroradiology &
Magnetic Resonance. He
was appointed as adjunct
professor of radiology/
nuclear medicine by the
F. Edward Hebert School
of Medicine, Uniformed
Services University of the
Health Sciences, Bethesda
Maryland.
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GRANTS
obert Myerson, PhD,
ID, professor of radiology,
s principal investigator,
'ceived a National Instiites of Health grant for
esearch on "Simultaneous
iiermoradiotherapy for
ireast carcinoma." Coinvesigators for the grant are
Eduardo Moros, PhD,
associate professor of radiology; William Straube,
MS, instructor in radiology;
Marie Taylor, MD, instructor in radiology; and Carlos
Perez, MD, professor of
radiology and director of the
Radiation Oncology Center.
Nobuyuki Oyama, MD,
PhD, visiting instructor in
radiology, received a 2000
CaP CURE Research Award
from the Association for
the Cure of Cancer of the
Prostate (CaP CURE) to
fund research for one year
on "PET imaging of prostate
cancer recurrence: earlier
diagnosis and treatment
leading to better quality of
life and prognosis." Coinvestigators for the $100,000
award are MIR's Tom
Miller, MD, PhD, professor
of radiology; Barry Siegel,
MD, professor of radiology
and of medicine; Farrokh
Dehdashti, MD, associate
professor of radiology; Jeff
Michalski, MD, assistant
professor of radiology; and
Michael Welch, PhD, professor of radiology and of
chemistry; and Washington
University's Adam Kibel,
MD; Gerald Andriole, MD;
and Joel Picus, MD.
Joseph Roti Roti, PhD,
professor of radiology,
associate director of the
Radiation Oncology Center,
and chief of cancer biology,
as principal investigator,
received a five-year,
$1.4 million grant from the
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National Cancer Institute to
study the molecular mechanisms that allow hyperthermia to kill cancer cells.
Jeffrey Williamson, PhD,
professor of radiology, as
principal investigator,
received a five-year grant
from the National Institutes
of Health for research on
"Heterogeneity corrections
in brachytherapy." Coinvestigators are Joseph Deasy,
PhD, assistant professor of
radiology; Clifford Chao,
MD, assistant professor of
radiology; and David Rogers,
PhD, National Research
Council of Canada. Collaborators on the grant are
Sicong Li, DSc, research
associate; Milos Vicic,
PhD, research associate;
and Randal Baker, PhD, Los
Alamos National Laboratory.

HONORS/
AWARDS
Kyongtae Bae, MD, PhD,
assistant professor of radiology, received an Editor's
Recognition Award of
Distinction 2000 from the
journal Radiology.
Louis Gilula, MD, professor
of radiology and of surgery,
was named organizer of the
International Wrist Investigative Workshop held in October in Seattle, Washington.
Barry Siegel, MD, professor
of radiology and of medicine
and director of the Division
of Nuclear Medicine,
received the American Board
of Radiology's Distinguished
Service Award for his "time, .
expertise, and energy
donated toward the American Board of Radiology's
certification process."

Carolyn Anderson, PhD,
associate professor of radiology, presented "Copper64-labeled somatostatin
analogs for cancer imaging
and therapy" at the American Chemistry Society
Regional Meeting, St. Louis,
Missouri, October 26.
Jeffrey Brown, MD, associate professor of radiology,
director of clinical research,
and codirector of magnetic
resonance imaging, presented "Abdominal MRA"
and "MRI of the kidneys and
pancreas" to the Colorado

Radiological Society, Denver, October 19. He spoke
on "MRI of the female
pelvis" at Grand Rounds at
the University of Colorado
Department of Radiology,
Denver, October 20.
Clifford Chao, MD, assistant
professor of radiology, spoke
on "Head and neck IMRT:
Washington University
experience" at the IMRT
Symposium: From Physics to
Clinical Medicine, Milan, Italy,
September 27-October 4.

MIR receives digital
patient monitoring
systems
Under a purchase agreement between Invivo
Research, Inc. of Orlando, Florida, and MIR investigators Thomas Conturo, MD, PhD, and Robert Gropler, MD, chief of the cardiovascular imaging
laboratory, MIR received two of the nation's first
Invivo MAGNITUDE® MRI-compatible digital monitoring systems, which received U. S. Food and Drug
Administration approval in September, 2000. This
revolutionary technology will provide more reliable,
noninvasive physiologic monitoring (heart rate, oxygen saturation, and blood pressure), invasive monitoring (arterial blood pressure), anesthesia
monitoring (nitrous oxide, oxygen, and 5 vaporized
anesthetics), and cardiac and pulse gating of MR
imaging acquisitions. The MAGNITUDE15 systems will
be used for neurologic and cardiac imaging research
in MIR's East Building.
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Continued from page 21
Colin Derdeyn, MD, assistant professor of radiology,
as invited lecturer, spoke on
"Emerging therapies: intraarterial thrombolysis and
carotid angioplasty and
stenting" at the Stroke
Prevention and Treatment
in the New Millennium
Symposium, sponsored
by The Stroke Center at
Washington University,
St. Louis, October 14.
Louis Gilula, MD, professor of radiology and of
surgery, as visiting professor, presented "Ligamentous
instabilities of the wrist" at
the University of California,
San Diego, August 18. He
spoke on "Technical problems of vertebroplasty and
how to handle them" at the
International Skeletal Society, Barcelona, Spain, September 15. Gilula presented
"Imaging approach to wrist
pain" to the American Society of Plastic Surgeons,
Los Angeles, October 11.
He presented "Vertebroplasty in osteoporosis" to
the National Rehabilitation
Society, San Francisco,
November 3. He spoke on
"Kyphoplasty vs. vertebroplasty" at the Update on
Spine Treatment, St. Louis,
Missouri, November 11.
Perry Grigsby, MD, MBA,
professor of radiology,
presented "Post-operative
management of endometrial
carcinoma" to the Jacksonville Area Gynecologists/
Oncologists Society, Jacksonville, Florida, August 22.
He spoke on "Cervical cancer: combined modality therapy" at the 2nd Annual
National Oncology Forum,

Chicago, Illinois, October 1415. Grigsby presented "FDGPET imaging for carcinoma
of the cervix" and "Carcinoma of the thyroid in
women" at the 10lh European
InterUniversity Symposium:
Highlights in Female Cancers, Thessaloniki, Greece,
November 2-5. He spoke on
"Carcinoma of the ovary:
role of radiotherapy" at the
First International Conference of Rajiv Gandhi Cancer
Institute and Research Center, Delhi, India, November
30-December 1.
Jay Heiken, MD, professor
of radiology, chief of abdominal radiology, and codirector of body computed
tomography, spoke on "Contrast media physiology for
multidetector CT," "Imaging
of the liver and pancreas
with multidetector CT," and
"CT colonography: state of
the art" at CT in the Year
2000: Multidetector and
Trauma CT, Milan, Italy,
October 6 and 7. He presented "Radiology of small
bowel obstruction: role of
plain films, CT, and barium
studies" and "Spiral CT for '
the evaluation of patients
with renal colic: Do we still
need IVP?" at the Eighth
Annual Radiology Update for
the Clinician, Carbondale,
Illinois, November 4.
Anil Khosla, MD, instructor in radiology, spoke on
"High resolution BOLD
venography in tumors" at the
All India Institute of Medical
Sciences, New Delhi, India,
August 5. He presented
"Extramedullary cysts of
spine" at the Delhi Radiology
Association, New Delhi,
India, August 8.

Moros discusses radiofrequency exposure systems
In response to public concern about the possible
health hazards caused by radiofrequency exposure,
the U.S. Food and Drug Administration has formed
the Radiofrequency Micronucleus Working Group.
Eduardo Moros, PhD, associate professor of radiology, was invited to join this national and international
team of scientific/technical experts. At the group's initial meeting in August in RockvUle, Maryland, Moros
discussed the in vitro radiofrequency exposure systems and dosimetry research and development performed at MIR's Radiation Oncology Center. This
public meeting was the first step of the Cooperative
Research and Development Agreement formed
between the FDA's Center for Devices and Radiological Health and the Cellular Telecommunications
Industry Association.

Jason Lewis, PhD, research
instructor in radiology, presented "Positron emission
tomography (PET) as a diagnostic tool in oncology" at
Pharmacia, St. Louis, Missouri, October 5. Lewis
spoke on "Copper-64-labeled
somatostatin analogs for
cancer imaging and therapy"
at the American Chemistry
Society Regional Meeting, St.
Louis, Missouri, October 26.
Daniel Low, PhD, assistant
professor of radiology, spoke
on "Difference between
IMRT and conformal therapy" at University of Wisconsin, Madison, October 13,
and at the Marconi Users
Group Meeting, Boston,
Massachusetts, October 20.

Robert McKinstry, MD,
PhD, assistant professor of
radiology, as invited speaker
for the American Medical
Association/Intel Health Internet Roadshow, presented
"Novice Internet training,"
"Web resources for physicians," "Web resources for
consumers," and "Solutions
for enhancing your practice
to the Michigan State Medic,;il
Society, Beverly Hills, Mich
gan, September 14, and "Wi
resources for physicians" a 1
"Solutions for enhancing yr ir
practice" to the Kentucky
State Medical Society,
Louisville, September 21.
He spoke on "Diffusion ten; r
imaging of human neural
development" at the Mappii
Function and Anatomy in th
Brain Symposium, sponson
by the Department of Radio
ogy, Michigan State Universi
East Lansing, November 3.

22

MALLINCKEODT INSTITUTE OF RADIOU

ff Michalski, MD, assis1 it professor of radiology,
j -sented "Radiation therapy
a T localized prostate cancer"
; i he University of Arkansas
I clical Center, Fort Smith,
,L ptember 7. He spoke on
' ew perspectives on
j (state cancer: redefining
j ;iient care" at the Medical
I .lucation Collaborative, New
K ork City, New York, Septemi or 23. Michalski presented
' New perspectives on
i .restate disease: redefining
1 latient care" at the Medical
Education Collaborative, St.
Louis, Missouri, October 27.
lie spoke on "3D CRT and
IMRT in pediatric clinical
trials" at the Children's
Oncology Group Meeting,
Phoenix, Arizona, November
2. Michalski presented
"Pediatric brain tumor trials
in the Children's Oncology
Group" to the Greater St.
Louis Society of Radiologists, St. Louis, Missouri,
November 21.
Scott Mirowitz, MD, professor of radiology, chief of
radiology at Barnes-Jewish
Hospital north, and codirector of body magnetic resonance imaging, as visiting
professor, presented "MRI
artifacts: challenges and
solutions" and "MRI of the
rotator cuff: techniques and
interpretation at Grand
Rounds" to the Department
of Radiology, University of
Missouri Medical Center,
Columbia, October 31.

Robert Myerson, PhD,
MD, professor of radiology,
spoke on "A joint U.S.-Italian
phase I/II trial of three
dimensionally planned concurrent boost radiotherapy
and protracted venous infusion of 5FU chemotherapy
for locally advanced rectal
carcinoma: response to
treatment," Rome, Italy,
November 17.
Vamsidhar Narra, MD,
assistant professor of radiology, presented "3D contrast
enhanced MRA" to the
Illinois State Society of
Radiologic Technologists,
Collinsville, Illinois, September 22. He presented "3D
contrast enhanced MRA
and the value of VIBE" at
William Beaumont Hospital,
Royal Oak, Michigan, October 4. He spoke on "MRCP
for clinicians" at Michigan
State University, Flint, October 5. Narra presented "3D
CE MRA" at the University
of Louisville, and "MRCP" to
the Greater Louisville Radiological Society, Louisville,
Kentucky, October 18. He
spoke on "Dynamic MRI in
the evaluation of pelvic floor
abnormalities" at the 86"'
Annual College of the American College of Surgeons,
Chicago, Illinois, October 25.
He presented "MRCP clinical applications: Can MRCP
replace ERCP?" to the
Carbondale Radiological
Society, Carbondale, Illinois,
November 4.
Nobuyuki Oyama, MD,
PhD, visiting instructor in
radiology, as invited lecturer,
presented "Clinical use of
PET imaging in prostate
cancer" to the Division of
Nuclear Medicine, University
of Washington, Seattle,
August 28.

FOCAL SPOT, FALL/WINTER 2000

James Purdy, PhD, professor of radiology, associate
director of the Radiation
Oncology Center, and chief
of radiation oncology
physics, as invited lecturer,
presented "Dose-volume
specification and reporting
for radiation oncology,"
"Quality assurance of 3D
treatment planning systems," "Quality assurance
of 3D CRT and IMRT
multi-institutional trials,"
and "Intensity modulated
radiation therapy" at the
4'" Annual National Symposium for Radiation Oncology, Johannesburg, South
Africa, August 21 and 22.
As invited speaker, he
presented "Image-based
treatment planning" at the
University of Witwaterstrand, Johannesburg, South
Africa, August 23. Purdy
spoke on "Review of ICRU
Reports 50 & 62: prescribing,
recording, and reporting photon beam therapy" and "Radiation therapy in the new
millennium: future directions"
at Tygerberg Hospital, Cape
Town, South Africa, August 29
and 30.
Marcus Raichle, MD,
professor of radiology and
of neurology and neurobiology and codirector of the
Division of Radiological
Sciences, as the invited
Willis Lecturer, presented
"A default mode of brain
function" to the Montreal
Neurological Institute, Montreal, Canada, September 21.

Joseph Roti Roti, PhD,
professor of radiology,
associate director of the
Radiation Oncology Center,
and chief of cancer biology,
as invited speaker, presented "Using animals to
assess health effects of
radiofrequency radiation
from cell phones" to the
Metro St. Louis Branch
Association of Laboratory
Animal Science, St. Louis,
Missouri, October 19.
Stuart Sagel, MD, professor of radiology, chief of
chest radiology, and codirector of body computed
tomography, spoke on "CT
of asbestos-related thoracic
disease," "CT of the pleura,"
"CT of non-vascular mediastinal masses," and "Problematic case discussions"
at the Summer Practicum of
the Society of Computed
Body Tomography and Magnetic Resonance, Whistler,
British Columbia, August
13-17. He spoke on "CT
angiography for pulmonary
embolism" and "CT of the
thorax: anatomic variants
and pitfalls" at the South
Florida and University of
Miami Radiological Meeting,
Miami, Florida, September
20. As visiting professor,
Sagel presented "CT of
non-vascular mediastinal
masses," "CT of the thorax:
anatomic variants and pitfalls," and "CT angiography
for pulmonary embolism"
to the Department of Radiology, Brown University,
Providence, Rhode Island,
October 2.
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LECTURES/PRESENTATIONS
Continued from page 23
Barry Siegel, MD, professor of radiology and of
medicine and director of
the Division of Nuclear
Medicine, spoke on "PET in
nuclear oncology: clinical
applications" at the 7th Asia
and Oceania Congress of
Nuclear Medicine and Biology/41* International Congress of Nuclear Oncology,
Istanbul, Turkey, October 2.
In celebration of the opening of the first PET center in
Turkey, Siegel, as invited
speaker, presented "Oncological applications of PET"
at International Hospital,
Istanbul, October 3. He
presented "PET imaging in
oncology: overview of tumor
imaging" and "Choices in
positron imaging: PET" at
the 14th Annual Northeast
Regional Scientific Meeting
of the New England and
Greater New York Chapters
of the Society of Nuclear
Medicine, Newport, Rhode
Island, November 3 and 4.

Marilyn Siegel, MD, professor of radiology and of
pediatrics, spoke on "Mediastinal CT: pitfalls in children and adolescents,"
"Pediatric abdominal
masses: imaging strategies,"
"Adolescent gynecologic
lesions: CT/MRI," and
"Pediatric kidney" at the
10th Summer Practicum of
the Society of Computed
Body Tomography and Magnetic Resonance Imaging
Meeting, Whistler, British
Columbia, August 13-17. As
an invited speaker, she presented "CT of the pediatric
mediastinum" and "Spiral
CT of the liver in children"
at the Spiral/Helical CT
2000: National Symposium,
Las Vegas, Nevada, September 7 and 8. As an invited
guest speaker, she presented
"CT/MR of pediatric
retroperitoneal tumors,"
"Hepatic CT in children,"
"Ultrasonography of acute
abdominal pain in children,"
and "MR imaging of bone
marrow" at the New Orleans
Fall Radiology Conference,
New Orleans, Louisiana, .
September 21 and 22. Siegel
spoke on "CT/MR imaging of
abdominal pediatric tumors"
at the International Cancer
Imaging Society, 1st Annual
Teaching Course, London,
England, October 9 and 10.
She presented "Sonography
of neonatal intracranial
hemorrhage and ischemia,"

"Pediatric gynecologic ultrasonography," "Ultrasonography of neonatal renal
disease," "Ultrasonography
of acute abdominal pain in
children," "CT of the pediatric kidney," and "CT and
MRI of pediatric pelvic
masses" at the 29"' Brazilian
Congress of Radiology,
Salvador da Bahia, Brazil,
November 12-15.
Jason Sohn, PhD, assistant
professor of radiology, as
invited lecturer, presented
"Intensity modulated radiation therapy" at the Korean
Society of Medical Physicists
Annual Meeting, September
22 and 23; at Seoul National
University Medical School,
September 25; at Samsung
Medical Center, September
27; and at Hallym University
Medical Center, Seoul,
Korea, September 27.
Marie Taylor, MD, instructor in radiology and chief of
breast service, presented
"Neoadjuvant therapyradiation management for
operable breast cancer"
and "Management of localregional recurrence after
definitive treatment of operable breast cancer" at the
Breast Cancer Symposium
2000, Bangkok, Thailand,
November 9 and 10.
Jerold Wallis, MD, associate professor of radiology,
spoke on "Web-based image
interpretation" at the Missouri Valley Chapter of the
Society of Nuclear Medicine
Annual Chapter Meeting,
Des Moines, Iowa, October 8.

Todd Wasserman, MD,
professor of radiology, presented "Protectors" at the
Institute of Oncology, Chaim
Sheba Medical Center, TelHashomer, Israel, August 17,
and to the Cancer Education
Program-Tumor Board,
Elkhart General Healthcare
System, Elkhart, Indiana,
December 20. He presented
"Radiation protectors in
clinical radiotherapy" to the
Oncology Department of
Rambam Medical Center,
Haifa, Israel, August 21. He
spoke on "Adjunctive care
of the cancer patient: optimizing nutritional status for
improved outcomes" at the
SynerMed Development
Meeting, Philadelphia,
Pennsylvania, September 9.
Wasserman spoke on
"Ethyol and its clinical bene
fits" at the U.S. Oncology
Fall Conference, Phoenix,
Arizona, October 9. He
spoke on "Overviews of
head and neck cancer and
new strategies in radioprotection" at Medicom of
Princeton, Inc., Augusta,
Maine, November 27. He
spoke on "Ethyol as a radioprotectant in head and neck
cancers" at Medicom of
Princeton, Inc., Cape Elizabeth, Maine, November 28
Michael Welch, PhD, professor of radiology and of
chemistry and codirector f
the Division of Radiologic 1
Sciences, presented "Cu64-pyruvaldehyde-Ms(N4methylthiosemicarbazon(
(Cu-64-PTSM) as a radiotherapy agent to prevent i e
growth of tumors at woui 1
sites following laparosco] "
at the EANM Congress,
Paris, France, September
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SYMPOSIA
In this section ofFYI, only
those faculty and staff who
have MIR appointments are
listed.

AMERICAN SOCIETY FOR
THERAPEUTIC RADIOLOGY AND ONCOLOGY
(ASTRO)
42nd Annual Meeting
Boston, Massachusetts
October 22-26, 2000

Melson Visiting
Professorship and Lecture
On September 25, Barbara Hertzberg, MD, professor
of radiology and associate professor of obstetrics and
gynecology at Duke University, presented the Eighth
Annual G. Leland Melson Visiting Professorship and
Lecture, "Ultrasound evaluation for ectopic pregnancy." Hertzberg received a commemorative plaque
from (left to right) Drs. Jay Heiken, chief of abdominal radiology; Sharlene Teefey, ultrasound; and
William Middleton, head of ultrasound.

Jeffrey Williamson, PhD,
professor of radiology, as
invited speaker, presented
"Dosimetry & calibration of
low energy brachytherapy
sources" at the Council of
Ionizing Radiation Measurements and Standards Workshop on a Measurements
and Standards Infrastructure
for Brachytherapy, Washington, DC, October 30 and 31.

FOCAL SPOT, FALL/WINTER 2000

Franz Wippold, MD, associate professor of radiology
and chief of neuroradiology,
spoke on "Laryngeal cancer
imaging" and "Cervical lymph
nodes-anatomy and pathology" at the University of
Montreal and at McGill University, Montreal, Canada,
September 12. He presented
"Imaging the post therapy
oral cavity and oropharynx"
and a film interpretation session at the XV International
Congress of Head and Neck
Radiology, Kumamoto,
Japan, October 19.

James Purdy, PhD, ASTRO
Gold Medal Award recipient.
Imran Zoberi, MD, ASTRO
Research Fellow Award
recipient.

REFRESHER COURSE
David Gius, MD, PhD,
"Novel combinations of
biologic and radiation therapy—emphasizing gene and
anti-angiogenic therapeutic
strategies."

SCIENTIFIC SESSIONS
Ana Botero, MD; Clifford
Chao, MD; Ineke Duijndam, MD; Joseph Simpson, MD, PhD; Carlos
Perez, MD, "High dose
radiation therapy yields
satisfactory tumor control
and the quality of voice as
compared with those of
hemilaryngectomy in early
stage glottic carcinoma."
Jeffrey Bradley, MD;
Joseph Deasy, PhD;
James Purdy, PhD; Todd
Wasserman, MD; Nantakan Ieumwananonthachai, MD; Mary Ann
Lockett, MBA, "Gross
tumor volume is an independent predictor of survival in
non-small cell lung carcinoma patients treated with
conformal radiotherapy."

Mustafa Cengiz, MD; Clifford Chao, MD; Carlos
Perez, MD, "Intensity-modulated radiotherapy (IMRT)
with concurrent cisplatin
chemotherapy (CT) yields
superior therapeutic outcome than conventional
techniques with or without
chemotherapy in locally
advanced nasopharyngeal
carcinoma."
Clifford Chao, MD;
Joseph Deasy, PhD;
Joanne Markham, MS;
Carlos Perez, MD; James
Purdy, PhD; Daniel Low,
PhD, "Functional outcome
of parotid gland sparing in
patients with head and neck
(H&N) cancers receiving
intensity-modulated (IMRT)
or 3-D radiation therapy."
Clifford Chao, MD; Perry
Grigsby, MD; Kim
Nguyen, dosimetry QA specialist; James Dempsey,
PhD; Fritz Lerma, PhD;
Kyongtae Bae, MD, PhD;
Jeffrey Williamson, PhD,
"Prospects for image-based
dose planning of intracavitary brachytherapy: registration of serial-imaging studies
using deformable anatomic
templates."
Perry Grigsby, MD, MBA,
"Long-term follow-up of
RTOG 92-10: cervical cancer
with positive para-aortic
lymph nodes."
Chih-Jen Huang, MD;
Clifford Chao, MD; Carlos
Perez, MD; Daniel Low,
PhD, "Tumor response and
salivary function sparing in
patients with oropharyngeal
squamous cell carcinoma
treated with intensity
modulated radiation therapy
(IMRT) with/without
chemotherapy: The
Mallinckrodt Institute of
Radiology initial results."
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Shervin Karimpour, MD;
Christopher Bradbury,
research technician; Imran
Zoberi, MD; Ana Botero,
MD; David Gius, MD, PhD,
"The role of thioredoxin
reductase in the regulation
of AP-1 DNA-binding activity
and in the cytotoxic
response to ionizing
radiation."

Marie Taylor, MD; Carlos
Perez, MD; Mary Ann
Lockett, MBA, "The effect
of medical co-morbidities of
diabetes, hypertension and
obesity on the incidence
of arm edema after breast
conservation therapy for
stage I and II breast cancerpatients."

Eric Klein, MS; Daniel
Low, PhD, "Interleaf leakage testing for 0.5 and
1.0 CM DMLC systems incorporating patient motion."

Jeffrey Williamson, PhD,
"Prospects for image-based
dose planning of intracavitary brachytherapy: registration of serial imaging studies
using deformable anatomic
templates."

Daniel Low, PhD; James
Dempsey, PhD; Joanne
Markham, MS; Sasa
Mutic, MS; Jeffrey
Williamson, PhD; James
Purdy, PhD, "Applicatorguided intensity modulated
radiation therapy."
Jeff Michalski, MD; James
Purdy, PhD; Carlos Perez,
MD; William Harms, BS,
"Update of toxicity following
3D radiation therapy for
prostate cancer on RTOG
9406."
Jeff Michalski, MD; Walter Bosch, DSc, "Mean dose
of radiation to the bulb of
the penis correlates with risk
of impotence at 24 months:
preliminary analysis of Radiation Therapy Oncology
Group (RTOG) phase WI
dose escalation trial 9406."
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Imran Zoberi, MD, "The
role of thioredoxin in the
regulation of AP-1 DNAbinding and cytotoxicity
in response to ionizing
radiation."
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Scott Lecture
Ronald Evens, MD, president of Barnes-Jewish
Hospital and former director of Mallinckrodt Institute,
was the Eg* Annual Wendell G. Scott Memorial Lecturer.
On October 16 in Scarpellino Auditorium, Evens spoke
on "Radiology from a hospital president's point of view."

POSTER PRESENTATIONS
Joseph Deasy, PhD,
"Acceleration of monte carlo
dose calculations via denoising techniques."
Robert Drzymala, PhD;
Jason Sohn, PhD; Eric
Klein, MS, "Preliminary '
study for frameless spinal
radiosurgery using a stereooptic camera system."
Todd Grigereit, PhD;
Daniel Low, PhD; Jennifer
Britt, dosimetry QA specialist; Jeffrey Bradley, MD,
"Helical arc radiation
therapy."

William Harms, BS; Russell Gerber, MS; James
Purdy, PhD, "Three dimensional conformal radiation
therapy treatment planning
and delivery verification
for multi-institutional dose
escalation trials using an
anthropomorphic phantom."
Jacob Locke, MD; Imran
Zoberi, MD; Douglas
Spitz, PhD; David Gius,
MD, PhD, "Indomethacin
induced inhibition of AP-1
DNA-binding activity inhibits
resistance of H202-resistant
tumor cells to the cytotoxicity of hyperthermia, H202,
and CIS-platin."

Robert Myerson, PhD,
MD; Anurag Singh, MD;
Mary Ann Lockett, MBA.
"Pre-treatment clinical findings predict outcome following preoperative radiation
for rectal cancer."
Jason Sohn, PhD; Dank
Low, PhD; Eric Klein, MS,
"Dynamic multileaf collim
tor performance for Intensity
Modulated Radiation
Therapy."
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IOLOGICAL SOCIETY
ORTH AMERICA

m
Scientific Assembly

■a?< Annual Meeting
\C1 ago, Illinois
\N< •mber26ID< •mber 1,2000

Louis Gilula, MD, presiding
■officer, Musculoskeletal
■(elbow, hand, and wrist).
J; Heiken, MD, presiding
■officer, Gastrointestinal
((T colonography: technical
advances); keynote speaker,
I Gastrointestinal.
Gilbert Jost, MD, session
[chair, Integrating the
fealthcare Enterprise (IHE):
clinical goals and technical
I challenges.
William Middleton, MD,
presiding officer, Musculoskeletal ultrasound.
Barry Siegel, MD, speaker,
Opening Session, Positron
emission tomography in
clinical practice.
Pamela Woodard, MD,
I presiding officer, Chest
(pulmonary embolism:
improving results).

FOCUS SESSION
Steven Don, MD, "Potential
for reduced exposure
to neonates through the
use of chest computed
radiography."

SCIENTIFIC EXHIBITS
Anil Khosla, MD; Franz
Wippold, MD; Fred
Hodges, MD, "Extramedullary cysts of spinal
canal."
JeffMichalski, MD; Sasa
Mutic, MS; John Eichling,
PhD; Nisar Ahmed, MD,
"Measured patient and
family radiation exposure
from permanent prostate
brachytherapy."

FOCAL SPOT, FALL/WINTER 2000

Mehdi Poustchi-Amin,
MD; Pamela Woodard,
MD; Fernando Gutierrez,
MD; Jeffrey Brown, MD;
Scott Mirowitz, MD; Vamsidhar Narra, MD, "Practical cardiac MRI: principles
and applications, a review
for the general radiologist."

REFRESHER COURSES
Dennis Balfe, MD, "Imaging
the invisible: mesenteries and
peritoneum of the upper
abdomen."
Jeffrey Brown, MD, "MR
of the genitourinary tract."
Joseph Deasy, PhD,
"Update course in diagnostic
radiology physics: radiation
therapy optimization and
intensity-modulated radiation therapy—radiobiological issues of optimization
and intensity-modulated
radiation therapy."
Louis Gilula, MD, "Vertebroplasty: indications,
technique, problems, and
complications;" "Imaging
upper-extremity trauma with
plain films, CT, and MR;"
"Wrist and hand injuries."
Fernando Gutierrez, MD,
"Update course in pediatric
radiology: imaging advances
in 2000—cardiovascular
disease. Vascular anomalies:
mediastinum and lung."
Jay Heiken, MD, "Acute
abdomen: CT evaluation."
David Hovsepian, MD,
"Hysterosalpingography and
selective salpingography
('how-to' workshop)."
Elizabeth McFarland, MD,
"CT of the small bowel and
colon: principles, techniques,
and applications."

Probstein Oncology
Lecture
The Norman K. Probstein Oncology Lecture, in recognition of meritorious contributions to oncology, was
presented on November 3 by Jonathan Epstein, MD,
professor of pathology at Johns Hopkins University
School of Medicine. He spoke on "Prognostic factors
in prostate cancer."

JeffMichalski, MD, "Radiation therapy for prostate
cancer: dose escalation
with 3D conformal radiation
therapy."
William Middleton, MD,
"Musculoskeletal US ('handson' workshop);" "Practical
tips in ultrasound: hand and
wrist."
James Purdy, PhD,
"Update course in diagnostic
radiology physics: radiation
therapy optimization and
intensity-modulated radiation therapy—optimized
treatment planning."

David Rubin, MD, "Imaging
upper-extremity trauma with
plain films, CT, and MR:
shoulder injuries."
Stuart Sagel, MD,
"Digital chest radiography:
techniques and clinical
applications."
Barry Siegel, MD, "Optimizing PET interpretation."
Marilyn Siegel, MD,
"Update course in pediatric
radiology: imaging advances
in 2000—pelvis: US, CT, or
MR imaging? Uterine anomalies;" "Pediatric MR imaging: abdominal masses."
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SCIENTIFIC SESSIONS
Kyongtae Bae, MD, PhD;
Alvaro Huete, MD; Farrokh Dehdashti, MD; Jay
Heiken, MD, "Characterization of adrenal adenoma
with PET in oncology
patients."
Kyongtae Bae, MD, PhD;
Jeong Lee, MD; Bruce
Whiting, PhD; Jay Heiken,
MD, "Evaluation of multislice CT scan parameters for
renal artery stenosis depiction: in vitro analysis."
Thomas Conturo, MD,
PhD; Nicholas Lori; Erbil
Akbudak, PhD; Abraham
Snyder, MD, PhD; Robin
Guillory; Joshua Shimony,
MD, PhD, "MRI diffusion
tensor tracking of neuronal
pathways of the visual
system in living humans."
Juliet Fallah, MD; Marilyn
Siegel, MD, "Post-transplant lymphoproliferative
disorder and non-Hodgkins
lymphoma: comparison of
CT findings in abdominal
disease."
David Gierada, MD;
Thomas Pilgram, PhD;
Richard Slone, MD; Lora
Crouch, BSRT, "Reliability
of quantitative CT (QCT) in
determining emphysema
severity and distribution
in lung volume reduction
surgery candidates."

L'S

Louis Gilula, MD; Dallas
Peck, MD, "Percutaneous
vertebroplasty for severe
osteoporotic vertebral compression (vertebra plana)."
Jay Heiken, MD; Cary
Siegel, MD, "Attenuation
of renal cysts with conventional and spiral CT: a phantom study."
Ronan McDermott, MD;
Sharlene Teefey, MD;
William Middleton, MD;
Charles Hildebolt, DDS,
PhD, "The resistive index
in renal parenchymal disease: no correlation with
histopathological findings."
William Middleton, MD;
Sharlene Teefey, MD,
"Interobserver variability in
sonographic detection of
rotator cuff tears."
William Middleton, MD;
Sharlene Teefey, MD;
Cynthia Santillan, MD;
Elizabeth McFarland, MD;
Shadan Sadeghi, "Prospective evaluation of the incidence of testicular of
microlithiasis and its association with testicular tumors."
Scott Mirowitz, MD,
"Health services, policy, and
research;" "Radiology utilization patterns in an academic
based managed care setting."

Tolmach
Lecture
Norman Coleman,
MD, chief of radiation oncology at the
National Cancer
Institute/National
Institutes of Health
in Bcthcsda, presented the Ninth Annual Leonard J. Tolmach
Memorial Lecture on November 3. The lecture topic
was "Radiation oncology: linking technology and
biology in the treatment of cancer."

Pratik Mukherjee, MD,
PhD; Robert McKinstry,
MD, PhD, "Diffusion tensor
MR imaging of the reversible
posterior leukoencephalopathy syndrome."
Dallas Peck, MD; Louis
Gilula, MD, "Technical
problems and potential solutions in vertebroplasty."
Sharlene Teefey, MD;
William Middleton, MD,
"Detection of partial and full
thickness rotator cuff tears
in patients with a painful
shoulder: a comparison of
ultrasound, MRI, and arthroscopic surgery."

Bruce Whiting, PhD;
Kyongtae Bae, MD, PhD,
"Novel method of CT data
reduction by compression of
projection sinograms."
Dmitriy Yablonskiy, PhD,
"Gradient echo plural contrast imaging (GEPCI)—new
fast magnetic resonance
imaging technique for simultaneous acquisition of T2, Tl
(or spin density) and T2*weighted images."
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